Literature DB >> 16077418

Surgical ablation of atrial fibrillation with a novel bipolar radiofrequency device.

Stefano Benussi1, Simona Nascimbene, Giliola Calori, Paolo Denti, Zvi Ziskind, Samer Kassem, Giovanni La Canna, Carlo Pappone, Ottavio Alfieri.   

Abstract

OBJECTIVE: When used for epicardial ablation, unipolar devices do not predictably yield transmural scars. Bipolar radiofrequency proved highly effective on the animal model, but clinical experience is still initial. We describe acute electrophysiologic findings and follow-up results of epicardial ablation with a novel bipolar radiofrequency device.
METHODS: A bipolar ablator was used to perform a simplified left atrial lesion set in 90 consecutive patients with atrial fibrillation undergoing open heart surgery. Pacing thresholds were assessed during surgery to validate 24 pulmonary vein encircling lines (12 patients). Follow-up was 100% complete.
RESULTS: In 67 of 90 patients (84%), mitral valve disease was the main indication to surgery. Atrial fibrillation was continuous in 74 patients (82%) and intermittent in 16 patients (18%). Pacing threshold assessment showed a complete conduction block in 22 of 24 pulmonary vein couples (92%) after a single ablation and in all patients after doubling of the encircling lines. No complications related to the ablation procedure were recorded. The sinus rhythm restoration rate was 79% at 3 months, 87% at 6 months, and 89% (17/18 patients) at 1 year. Postablation organized arrhythmias consisted in right atrial flutter in 2 patients (2%) and left atrial flutter in 6 patients (7%).
CONCLUSIONS: Epicardial ablation with bipolar radiofrequency grants acute transmurality. A simplified lesion set proved highly effective in eliminating atrial fibrillation at 1-year follow-up. Our data suggest that addition of a lesion to the mitral annulus is advisable to prevent left atrial flutter.

Entities:  

Mesh:

Year:  2005        PMID: 16077418     DOI: 10.1016/j.jtcvs.2005.01.009

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

Review 1.  Bronchial thermoplasty: a novel therapy for severe asthma.

Authors:  Ajay Sheshadri; Mario Castro; Alexander Chen
Journal:  Clin Chest Med       Date:  2013-08-01       Impact factor: 2.878

2.  Left atrial ablation for atrial fibrillation: creating the "box lesion" with a bipolar radiofrequency device.

Authors:  Leonid Sternik; Hartzel V Schaff; David Luria; Michael Glikson; Alexander Kogan; Ateret Malachy; Maya First; Ehud Raanani
Journal:  Tex Heart Inst J       Date:  2011

Review 3.  How effective is bipolar radiofrequency ablation for atrial fibrillation during concomitant cardiac surgery?

Authors:  Sumoyee Basu; Myura Nagendran; Mahiben Maruthappu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-19

4.  Histological assessment of transmurality after repeated radiofrequency ablation of the left atrial wall.

Authors:  Satoru Wakasa; Suguru Kubota; Yasushige Shingu; Hiroki Kato; Tomonori Ooka; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-01-16

5.  Strategies to Improve the Efficacy of Epicardial Linear Ablation on the Beating Heart.

Authors:  Yoshiyuki Watanabe; Matthew R Schill; Toshinobu Kazui; Spencer J Melby; Richard B Schuessler; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2016 Nov/Dec

6.  Surgical ablation for atrial fibrillation: the efficacy of a novel bipolar pen device in the cardioplegically arrested and beating heart.

Authors:  Shun-ichiro Sakamoto; Rochus K Voeller; Spencer J Melby; Shelly C Lall; Nai-lun Chang; Richard B Schuessler; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2008-11       Impact factor: 5.209

Review 7.  Surgical Treatment of Atrial Fibrillation: Cutting Through the Edges.

Authors:  Amer Harky; Christiana Bithas; Jeffrey Shi Kai Chan; Mostafa Snosi; Dimitrios Pousios; Andrew D Muir
Journal:  Braz J Cardiovasc Surg       Date:  2020-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.